Benzinga's Top Upgrades

Analysts at Mizuho Securities upgraded LifePoint Hospitals LPNT from “neutral” to “buy.” The target price for LifePoint Hospitals has been raised from $58 to $72. LifePoint's shares closed at $60.87 yesterday. Raymond James upgraded Amsurg AMSG from “market perform” to “strong buy.” The target price for Amsurg is set to $60. Amsurg's shares closed at $45.74 yesterday. Analysts at JP Morgan upgraded Avery Dennison AVY from “neutral” to “overweight.” The target price for Avery Dennison has been raised from $52 to $58. Avery Dennison's shares closed at $49.21 yesterday. Analysts at Northland Securities upgraded OmniVision Technologies OVTI from “market perform” to “outperform.” The target price for OmniVision Technologies has been raised from $21 to $28. OmniVision's shares closed at $20.14 yesterday.